KONEF.US KetamineOne Capital Limited
- Market cap
- USD 1.30K
- P/E
- -
- P/B
- 0.02x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jul 2022.
Is KONEF.US undervalued?
Graham numberThe Graham number of KetamineOne Capital Limited cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
KetamineOne Capital Limited fundamental analysis
No fundamental analysis for KetamineOne Capital Limited yet.
KetamineOne Capital Limited stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About KetamineOne Capital Limited
Wellbeing Digital Sciences Inc., a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as KetamineOne Capital Limited and changed its name to Wellbeing Digital Sciences Inc. in January 2022. Wellbeing Digital Sciences Inc. was founded in 2017 and is headquartered in Vancouver, Canada.
Full company profileKetamineOne Capital Limited financial statements
KetamineOne Capital Limited annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 1.13M | 6.44M |
| Gross Profit | - | - | - | 0.00 | 793K | 424K |
| Operating Income | - | -287K | 5.39M | -609K | -7.66M | -23.8M |
| EBITDA | - | -287K | 5.39M | -532K | -7.66M | -23.8M |
| Net Income | - | -287K | -6.58M | 1.13M | -31.9M | -25.2M |
| EPS | - | 0.00 | -0.23 | 0.02 | -0.37 | -0.21 |
| Balance Sheet | ||||||
| Total Assets | 76.7K | 2.12M | 3.73M | 4.92M | 21.9M | 17.2M |
| Total Liabilities | 6.67K | 38.7K | 17.1K | 77.4K | 14.0M | 17.4M |
| Shareholders' Equity | 70.1K | 2.08M | 3.71M | 4.84M | 7.91M | -229K |
| Cash & Short-term Investments | 76.7K | 2.12M | 3.19M | 4.76M | 3.62M | 315K |
| Total Debt | - | - | - | 46.7K | 237K | 2.13M |
| Cash Flow | ||||||
| Operating Cash Flow | -69.8K | -210K | -638K | -590K | -2.28M | -3.64K |
| Capital Expenditure | 0.00 | 1.99K | 1.99K | 1.99K | 1.99K | 94.02 |
| Free Cash Flow | - | -210K | -638K | -590K | -2.28M | -3.73K |
| Ratios | ||||||
| ROE | - | -13.8% | -177.1% | 23.3% | -403.4% | - |
| ROA | - | -13.6% | -176.3% | 22.9% | -145.6% | -146.4% |
| Net Profit Margin | - | - | - | - | -2,821.3% | -391.3% |
| Debt to Equity | - | - | - | 0.01x | 0.03x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
KetamineOne Capital Limited dividends
KetamineOne Capital Limited has not paid dividends in the last 6 fiscal years.
Who owns KetamineOne Capital Limited
Ownership data of KetamineOne Capital Limited is not available yet.
KetamineOne Capital Limited company profile
- Company name
- KetamineOne Capital Limited
- Ticker
- KONEF.US
- ISIN
- CA4925561058
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- July
- Address
- 1917 West 4th Avenue, Vancouver, BC, Canada, V6J 1M7
- Website
- ketamine.one
About KetamineOne Capital Limited
Wellbeing Digital Sciences Inc., a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as KetamineOne Capital Limited and changed its name to Wellbeing Digital Sciences Inc. in January 2022. Wellbeing Digital Sciences Inc. was founded in 2017 and is headquartered in Vancouver, Canada.
KetamineOne Capital Limited management
3- Ms. Najla GuthrieCEO, Chief Research Officer & Director · born 1964
- Mr. Terry Zimaro C.A., CPAChief Financial Officer · born 1975
- Mr. Keith WhitePresident of Clinic Operations